Systen 3.2mg Transdermal Patch


Product Info

Prescription required Yes
Marketer JNTL Consumer Health (India) Pvt. Ltd.
Active Ingredient Estradiol (3.2mg)
Storage Store below 30°C
Chemical ClassEstradiol Congeners
Habit FormingNo
Therapeutic ClassGYNAECOLOGICAL
Action ClassEstrogens
User Rating4.8
User Reviews572

FAQ

Question
What are the most common side effects of using Systen 3.2mg Transdermal Patch?
The common side effects associated with Systen 3.2mg Transdermal Patch are application site reaction (redness, pain or itching), breast pain or tenderness, breakthrough vaginal bleeding, headache, nausea and stomach pain. If any of these side effects bother you, please consult with your doctor.
Answer

Question
Where to apply Systen 3.2mg Transdermal Patch?
It is applied to the skin. You can stick the patch on to a hairless area of skin below the waist. You can also use it in places like buttock, lower back, hip or abdomen. Make sure that the applied site is dry and clean.
Answer

Question
How should Systen 3.2mg Transdermal Patch be used?
Apply it exactly as advised by your doctor. It should be applied below the panty line and not on breasts or any other area of the body. You can also use it on your buttocks. Wash and dry the area before using. The area should be free of any cuts, bruises, lotions, or creams. When you change your patch, do not put the new one in the same place. To help reduce the chance of skin redness or irritation, wait at least 1 week before you reuse a spot.
Answer

Systen 3.2mg Transdermal Patch Reviews

Systen 3.2mg Transdermal Patch is a female sex hormone (estrogen). This is a hormone replacement therapy (HRT) that is used to treat symptoms associated with menopause (hot flushes, vaginal dryness and itching), estrogen deficiency (hypoestrogenism), and thinning of bones (osteoporosis).

Systen 3.2mg Transdermal Patch should be used as per the provided instructions by the doctor. Even if your symptoms improve, you should continue the treatment as it has been prescribed. The course of the treatment must be completed for better efficacy.

The most common side effects of this medicine include breast discomfort, abnormal menstrual bleeding, application site reactions, headache, nausea, abdominal pain, and abdominal distension. If any of these side effects bother you, consult your doctor. Also, tell your doctor if you notice bleeding from your vagina or develop breast lumps.

Before using this medicine you should tell your doctor if you have unexplained vaginal bleeding or if you have ever had a blood clot in your legs or your lungs. Once you have started using this medicine you should have regular check-ups to discuss the benefits of your treatment. It should not interact with any other medicines but it is not usually recommended during pregnancy or breastfeeding.

How Systen 3.2mg Transdermal Patch Works

Systen 3.2mg Transdermal Patch contains a medication called estrogen (female sex hormone). It works by replacing estrogen that is normally produced by the body.

How to Use Systen 3.2mg Transdermal Patch

Use this medicine in dose and duration as advised by your doctor. Check the label before use. Make sure the skin is clean and dry. Remove the protective liner of the patch. Do not touch the sticky side. With sticky side down, place the patch evenly onto the skin.

Benefits of Systen 3.2mg Transdermal Patch

  • In Hormone replacement therapy: Hormone placement therapy (HRT) is a treatment to relieve symptoms of menopause such as hot flushes, night sweats, mood swings, vaginal dryness, and reduced sex drive. Since menopause can last for several years, this treatment can make a big improvement to your daily life and mood. Estrogen is one of two important hormones (the other is progesterone) used in this treatment. You should use this medicine as it is prescribed, and for as long as it is prescribed by your doctor.

Uses of Systen 3.2mg Transdermal Patch

  • Hormone replacement therapy

Systen 3.2mg Transdermal Patch Side Effects

Item form

Safety Tips

Kidney  CAUTION
Systen 3.2mg Transdermal Patch should be used with caution in patients with kidney disease. Dose adjustment of Systen 3.2mg Transdermal Patch may be needed. Please consult your doctor.
Breast feeding  UNSAFE
Systen 3.2mg Transdermal Patch is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Liver  CAUTION
Systen 3.2mg Transdermal Patch should be used with caution in patients with liver disease. Dose adjustment of Systen 3.2mg Transdermal Patch may be needed. Please consult your doctor.Use of Systen 3.2mg Transdermal Patch is not recommended in patients who previously had liver disease and the liver function tests are still not normal.
Pregnancy  UNSAFE
Systen 3.2mg Transdermal Patch is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.

Quick Tips

  • Inform your doctor if you experience any unusual vaginal bleeding or spotting, abnormal vaginal discharge or vaginal discomfort while taking Systen 3.2mg Transdermal Patch.
  • Replace it every 7 days, and apply on a different area of skin to prevent skin irritation.
  • It has a lower risk of side effects since lower amount of estrogen is used in patches.
  • Stop using this medicine and inform your doctor immediately if you notice unexplained swelling and pain in your limbs, shortness of breath, chest pain, or changes in vision. These could be symptoms of a blood clot in a vein.
  • You have been prescribed Systen 3.2mg Transdermal Patch as a part of hormone replacement therapy to relieve symptoms of menopause.
  • Apply it once a week, to a clean, dry, unbroken, non-irritated area of skin below the waist, on the lower back or buttocks. Do not expose it to sunlight.
  • It may also be used for preventing osteoporosis in postmenopausal women who are at high risk of fractures.

References

  1. Estradiol. Luxembou: Merus Labs Luxco II S.à R.L; 2009 [revised 25 Apr. 2016].
  2. Central Drugs Standard Control Organisation (CDSCO).
  3. Levin ER, Hammes SR. Estrogens and Progestins. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1173-75.
  4. Oestradiol [Package Leaflet]. Uxbridge, UK: Norgine Pharmaceuticals Limited.
  5. Masters SB. Hypothalmic & Pituitary Hormones. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 701-702.
  6. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 500-501.
  7. Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198.

Other Medical Preparations